Among the diverse array of antidiabetic agents, the class of GLP-1 receptor agonists has garnered substantial attention not only for their glycemic control properties but also for their potential cardiovascular benefits (35)
GLP-1 agonists and tirzepatide may cause unpleasant side effects including dizziness, headache, indigestion or upset stomach, nausea, vomiting, diarrhoea and feeling jittery
The fundamentals, she says, are the same for everyone on the medications or not: enough protein, enough fiber, and nutrient-dense foods that are not overly processed
Using compounded medications for the management of obesity is not standard of care, Kashyap told Healio | Endocrine Today
However, its effects are milder and slower than GLP-1 drugs, so its not a direct substitute